Skip to main content

Advertisement

Log in

Immune functions, clinical parameters and hormone receptor status in breast cancer patients

  • ORIGINAL PAPER
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

We have carried out a detailed analysis of the cellular immune functions of breast cancer patients in comparison with healthy controls. A possible correlation between immune and clinical parameters was analysed in 50 breast cancer patients. Immune parameters, natural killer cell and T lymphocyte functions and the numbers of circulating T lymphocytes were analysed against the clinical parameters comprising the tumour burden, the stage of the disease and the expression of hormone receptors on the tumour. In order to analyse the immune function data effectively, low responders were identified with stringent cut-off values. Considerably higher proportions of low responders were found among the patient population. Elevated numbers of circulating T lymphocytes and CD3-directed cytolysis correlated with the expression of oestrogen receptors independently of the clinical/histological parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 11 September 1998 / Accepted: 7 December 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shevde, L., Joshi, N., Dudhat, S. et al. Immune functions, clinical parameters and hormone receptor status in breast cancer patients. J Cancer Res Clin Oncol 125, 313–320 (1999). https://doi.org/10.1007/s004320050280

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004320050280

Navigation